Axsome Therapeutics (AXSM) Return on Capital Employed Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4,853.00 |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | 3,986.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,986.00 |
| Dec 31, 2025 | 6,254.00 |
| Sep 30, 2025 | 425.00 |
| Jun 30, 2025 | 7,307.00 |
| Mar 31, 2025 | 13,262.00 |
| Dec 31, 2024 | 7,382.00 |
| Sep 30, 2024 | 2,851.00 |
| Jun 30, 2024 | -347.00 |
| Mar 31, 2024 | -818.00 |
| Dec 31, 2023 | 695.00 |
| Sep 30, 2023 | 1,479.00 |
| Jun 30, 2023 | 956.00 |
| Mar 31, 2023 | -816.00 |
| Dec 31, 2022 | -1,307.00 |
| Sep 30, 2022 | 3,084.00 |
| Jun 30, 2022 | -9,350.00 |
| Mar 31, 2022 | -13,398.00 |
| Dec 31, 2021 | 12,524.00 |
| Sep 30, 2021 | 9,846.00 |
| Jun 30, 2021 | -6,560.00 |
| Mar 31, 2021 | -11,625.00 |
| Dec 31, 2020 | -18,180.00 |
| Sep 30, 2020 | -15,750.00 |
| Jun 30, 2020 | -13,940.00 |
| Mar 31, 2020 | -13,517.00 |
| Dec 31, 2019 | -15,597.00 |
| Sep 30, 2019 | -18,238.00 |
| Jun 30, 2019 | -11,022.00 |
| Mar 31, 2019 | -10,888.00 |